Krystal Biotech Correlations
KRYS Stock | USD 187.15 1.46 0.77% |
The current 90-days correlation between Krystal Biotech and Apellis Pharmaceuticals is 0.23 (i.e., Modest diversification). The correlation of Krystal Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Krystal Biotech Correlation With Market
Average diversification
The correlation between Krystal Biotech and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and DJI in the same portfolio, assuming nothing else is changed.
Krystal |
Moving together with Krystal Stock
0.74 | CMRX | Chimerix | PairCorr |
0.66 | CPIX | Cumberland Pharmaceuticals | PairCorr |
0.69 | INMD | InMode | PairCorr |
0.67 | LUCD | Lucid Diagnostics | PairCorr |
0.68 | LUNG | Pulmonx Corp | PairCorr |
0.78 | PKX | POSCO Holdings | PairCorr |
Moving against Krystal Stock
0.82 | GKOS | Glaukos Corp | PairCorr |
0.78 | ELMD | Electromed | PairCorr |
0.73 | SNDL | SNDL Inc | PairCorr |
0.7 | MOLN | Molecular Partners | PairCorr |
0.63 | IPA | Immunoprecise Antibodies | PairCorr |
0.61 | CLDX | Celldex Therapeutics | PairCorr |
0.56 | VOR | Vor Biopharma | PairCorr |
0.51 | EYEN | Eyenovia | PairCorr |
0.39 | CRVS | Corvus Pharmaceuticals | PairCorr |
0.31 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.77 | ITGR | Integer Holdings Corp | PairCorr |
0.67 | LIVN | LivaNova PLC | PairCorr |
0.64 | INGN | Inogen Inc | PairCorr |
0.62 | MODD | Modular Medical | PairCorr |
0.58 | OTRK | Ontrak Inc | PairCorr |
0.57 | APYX | Apyx Medical | PairCorr |
0.55 | MDAI | Spectral AI | PairCorr |
0.38 | SGHT | Sight Sciences | PairCorr |
0.8 | RKV | Rakovina Therapeutics | PairCorr |
0.69 | KB | KB Financial Group | PairCorr |
0.67 | CNMD | CONMED | PairCorr |
0.61 | SRDX | SurModics | PairCorr |
0.48 | HYMTF | Hyundai Motor | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Krystal Stock performing well and Krystal Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Krystal Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
MGTX | 3.12 | 0.44 | 0.14 | (1.42) | 3.45 | 5.56 | 34.28 | |||
APLS | 2.16 | (0.34) | 0.00 | (0.41) | 0.00 | 4.11 | 20.77 | |||
DCPH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
RGNX | 3.48 | (0.05) | 0.00 | 7.14 | 0.00 | 7.80 | 17.69 | |||
RYTM | 1.95 | (0.02) | 0.00 | (0.32) | 0.00 | 4.49 | 13.95 |
Krystal Biotech Corporate Management
Christine Wilson | Head Marketing | Profile | |
David Chien | Senior Development | Profile | |
Hubert MD | Senior Development | Profile | |
Gloria Lin | Accounting Mang | Profile | |
Kathryn Romano | Executive Officer | Profile | |
Katherine Tuminello | HR Mang | Profile |